Curis (CRIS) Earnings Date & Reports

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CRIS is expected to report earnings to fall 67.00% to -825 cents per share on July 30

Q2'26

Est.

$-8.25

Q1'26

Missed

by $14.40

Q4'25

Beat

by $2.00

Q3'25

Beat

by $0.82

Q2'25

Beat

by $0.56

The last earnings report on May 12 showed earnings per share of -2500 cents, missing the estimate of -1060 cents. With 35.34K shares outstanding, the current market capitalization sits at 9.16M.

View a ticker or compare two or three

Compare

CRIS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CRIS